Bladder cancer study questions whether chemo skews MRI results
NCT ID NCT07202819
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This trial is investigating whether chemotherapy given before bladder removal surgery affects how accurate MRI scans are at staging muscle-invasive bladder cancer. Researchers will compare MRI results with actual tumor findings after surgery in 76 participants who either received chemo first or went straight to surgery. The goal is to understand if chemo-induced tissue changes make MRI less reliable.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Neoadjuvant chemotherapy (cisplatin-based regimens such as MVAC or gemcitabine and cisplatin)
What this could lead to
If successful, this study could help doctors know whether MRI scans remain reliable for staging bladder cancer after chemotherapy, improving treatment planning.
What could go wrong
This is a small, early-stage study focused on diagnostic accuracy, not a treatment. Results may not apply to all patients or change clinical practice directly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MUSCLE-INVASIVE BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Urology Department, Faculty of Medicine, Assiut University
NOT_YET_RECRUITINGAsyut, Asyut Governorate, 71515, Egypt
-
Urology Department, Faculty of Medicine, Assiut University
RECRUITINGAsyut, Asyut Governorate, 71515, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••